Colistimethate sodium - Cystic fibrosis
You are here : Home > Formulary Search > Colistimethate sodium - Cystic fibrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Colistimethate sodium
Indication :
Cystic fibrosis
Group Name :
Keywords :
NICE
Brand Names Include :
Colistin, Colomycin, Promixin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Colistimethate sodium is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Cystic fibrosis.
Committee Recommendations (2)
Implementation of NICE TA276 - No action required Colistimethate for Cystic Fibrosis is funded by NHS England from 1st April 2013
01 Apr 13 -
Not Set
FOR NEW PATIENTS ONLY. Prescribing of Colistimethate Sodium will be considered RED on the Prescribing Advisory database. Historically amber for CF patients via nebulisation / inhalation.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.